Open an account

Utah Medical Products

UTMD · NASDAQ

$75.07+$0.52 (+0.70%)TodayMarket closed ·
Prev close $74.55

About UTMD

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 140 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Employees
146
Headquarters
Midvale, Utah
Listed
Dec 1, 1982
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
utahmed.com

UTMD key statistics

Market cap
238.23M
Price-earnings ratio
22.73
Dividend yield
1.67%
Average volume
37.12K
Volume
39.46K
Open price
$74.80
High today
$75.09
Low today
$74.81
52 Week high
$76.89
52 Week low
$53.66

Utah Medical Products (UTMD) at a glance

As of Oct 20, 2026, Utah Medical Products (UTMD) shares are priced at $75.07, giving the company a market cap of 238.23M, a price-to-earnings ratio of 22.73 and a dividend yield of 1.67%.

Today the stock has traded between $74.81 and $75.09. The current price is 0.3% above the day's low and 0.0% below its high.

Volume so far is 39.46K shares, in line with the average of 37.12K shares a day.

Over the past year Utah Medical Products has ranged from $53.66 to $76.89, and now sits 92% of the way up that range.

Utah Medical Products met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY24 it reported $1.09 per share against an estimate of $0.00.

UTMD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 8.9% on average.

  1. Q1 FY13: reported $0.728 per share against an estimate of $0.714
  2. Q2 FY13: reported $0.70 per share against an estimate of $0.6324
  3. Q3 FY13: reported $0.68 per share against an estimate of $0.7038
  4. Q4 FY13: reported $0.92 per share against an estimate of $0.6528
  5. Q1 FY14: reported $0.72 per share against an estimate of $0.8058
  6. Q4 FY22: reported $1.25 per share against an estimate of $0.00
  7. Q2 FY23: reported $1.15 per share against an estimate of $0.00
  8. Q1 FY24: reported $1.09 per share against an estimate of $0.00

Similar companies

Companies in the same industry as Utah Medical Products

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.